NM_000939.4:c.282C>G

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_000939.4(POMC):​c.282C>G​(p.Ser94Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000193 in 1,556,550 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S94G) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0000014 ( 0 hom. )

Consequence

POMC
NM_000939.4 missense

Scores

5
13

Clinical Significance

Uncertain significance no assertion criteria provided U:1

Conservation

PhyloP100: 1.10

Publications

7 publications found
Variant links:
Genes affected
POMC (HGNC:9201): (proopiomelanocortin) This gene encodes a preproprotein that undergoes extensive, tissue-specific, post-translational processing via cleavage by subtilisin-like enzymes known as prohormone convertases. There are eight potential cleavage sites within the preproprotein and, depending on tissue type and the available convertases, processing may yield as many as ten biologically active peptides involved in diverse cellular functions. The encoded protein is synthesized mainly in corticotroph cells of the anterior pituitary where four cleavage sites are used; adrenocorticotrophin, essential for normal steroidogenesis and the maintenance of normal adrenal weight, and lipotropin beta are the major end products. In other tissues, including the hypothalamus, placenta, and epithelium, all cleavage sites may be used, giving rise to peptides with roles in pain and energy homeostasis, melanocyte stimulation, and immune modulation. These include several distinct melanotropins, lipotropins, and endorphins that are contained within the adrenocorticotrophin and beta-lipotropin peptides. The antimicrobial melanotropin alpha peptide exhibits antibacterial and antifungal activity. Mutations in this gene have been associated with early onset obesity, adrenal insufficiency, and red hair pigmentation. Alternatively spliced transcript variants encoding the same protein have been described. [provided by RefSeq, Jan 2016]
POMC Gene-Disease associations (from GenCC):
  • obesity due to pro-opiomelanocortin deficiency
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet, Ambry Genetics
  • inherited obesity
    Inheritance: SD, AD Classification: STRONG, LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.12171653).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000939.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
POMC
NM_000939.4
MANE Select
c.282C>Gp.Ser94Arg
missense
Exon 3 of 3NP_000930.1
POMC
NM_001035256.3
c.282C>Gp.Ser94Arg
missense
Exon 4 of 4NP_001030333.1
POMC
NM_001319204.2
c.282C>Gp.Ser94Arg
missense
Exon 4 of 4NP_001306133.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
POMC
ENST00000395826.7
TSL:2 MANE Select
c.282C>Gp.Ser94Arg
missense
Exon 3 of 3ENSP00000379170.2
POMC
ENST00000405623.5
TSL:1
c.282C>Gp.Ser94Arg
missense
Exon 3 of 3ENSP00000384092.1
POMC
ENST00000264708.7
TSL:2
c.282C>Gp.Ser94Arg
missense
Exon 4 of 4ENSP00000264708.3

Frequencies

GnomAD3 genomes
AF:
0.00000658
AC:
1
AN:
152072
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000242
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.00000142
AC:
2
AN:
1404478
Hom.:
0
Cov.:
33
AF XY:
0.00000144
AC XY:
1
AN XY:
693616
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31886
American (AMR)
AF:
0.00
AC:
0
AN:
36492
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25206
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36180
South Asian (SAS)
AF:
0.00
AC:
0
AN:
80054
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
48414
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5698
European-Non Finnish (NFE)
AF:
0.00000185
AC:
2
AN:
1082344
Other (OTH)
AF:
0.00
AC:
0
AN:
58204
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.550
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000658
AC:
1
AN:
152072
Hom.:
0
Cov.:
33
AF XY:
0.0000135
AC XY:
1
AN XY:
74286
show subpopulations
African (AFR)
AF:
0.0000242
AC:
1
AN:
41390
American (AMR)
AF:
0.00
AC:
0
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10612
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68006
Other (OTH)
AF:
0.00
AC:
0
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

POMC-related disorder Uncertain:1
Feb 23, 2024
PreventionGenetics, part of Exact Sciences
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

The POMC c.282C>G variant is predicted to result in the amino acid substitution p.Ser94Arg. To our knowledge, this variant has not been reported in the literature or in a large population database, indicating this variant is rare. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.34
BayesDel_addAF
Benign
-0.028
T
BayesDel_noAF
Benign
-0.28
CADD
Benign
12
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.52
D
Eigen
Benign
-0.77
Eigen_PC
Benign
-0.82
FATHMM_MKL
Benign
0.22
N
LIST_S2
Uncertain
0.95
D
M_CAP
Benign
0.021
T
MetaRNN
Benign
0.12
T
MetaSVM
Benign
-0.60
T
MutationAssessor
Benign
1.0
L
PhyloP100
1.1
PrimateAI
Uncertain
0.77
T
PROVEAN
Benign
-1.9
N
REVEL
Benign
0.085
Sift
Uncertain
0.0050
D
Sift4G
Benign
0.37
T
Polyphen
0.062
B
Vest4
0.19
MutPred
0.30
Loss of phosphorylation at S94 (P = 0.0098)
MVP
0.88
MPC
0.34
ClinPred
0.099
T
GERP RS
1.9
Varity_R
0.061
gMVP
0.21
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs28930368; hg19: chr2-25384472; API